Neuberger Berman Group’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $57.7M | Sell |
446,419
-117,414
| -21% | -$16.9M | 0.04% | 447 |
|
|
2025
Q4 | $80.4M | Sell |
563,833
-78,113
| -12% | -$10.5M | 0.06% | 363 |
|
|
2025
Q3 | $77M | Buy |
641,946
+122,995
| +24% | +$15.6M | 0.06% | 388 |
|
|
2025
Q2 | $68.6M | Buy |
518,951
+38,361
| +8% | +$5.2M | 0.05% | 395 |
|
|
2025
Q1 | $66.7M | Buy |
480,590
+1,894
| +0.4% | +$294K | 0.06% | 379 |
|
|
2024
Q4 | $74.3M | Buy |
478,696
+33,830
| +8% | +$5.72M | 0.06% | 360 |
|
|
2024
Q3 | $81.1M | Sell |
444,866
-151,838
| -25% | -$22.5M | 0.06% | 333 |
|
|
2024
Q2 | $70.9M | Buy |
596,704
+12,535
| +2% | +$1.32M | 0.06% | 343 |
|
|
2024
Q1 | $62.7M | Buy |
584,169
+164,828
| +39% | +$16.4M | 0.05% | 375 |
|
|
2023
Q4 | $41.8M | Sell |
419,341
-12,379
| -3% | -$1.21M | 0.04% | 463 |
|
|
2023
Q3 | $51.4M | Sell |
431,720
-31,829
| -7% | -$4.75M | 0.05% | 406 |
|
|
2023
Q2 | $82.6M | Sell |
463,549
-4,044
| -0.9% | -$742K | 0.07% | 311 |
|
|
2023
Q1 | $77.1M | Buy |
467,593
+24,345
| +5% | +$4.19M | 0.07% | 320 |
|
|
2022
Q4 | $69.8M | Buy |
443,248
+63,181
| +17% | +$9.61M | 0.07% | 334 |
|
|
2022
Q3 | $57.2M | Buy |
380,067
+116,619
| +44% | +$19.4M | 0.06% | 385 |
|
|
2022
Q2 | $43.3M | Buy |
263,448
+33,328
| +14% | +$6.42M | 0.04% | 461 |
|
|
2022
Q1 | $51.2M | Sell |
230,120
-152,194
| -40% | -$34.1M | 0.04% | 467 |
|
|
2021
Q4 | $90.7M | Buy |
382,314
+17,317
| +5% | +$4.05M | 0.07% | 348 |
|
|
2021
Q3 | $85.2M | Buy |
364,997
+46,770
| +15% | +$9.81M | 0.07% | 343 |
|
|
2021
Q2 | $65.5M | Buy |
318,227
+25,714
| +9% | +$5.29M | 0.06% | 408 |
|
|
2021
Q1 | $60.1M | Buy |
292,513
+5,340
| +2% | +$1.13M | 0.06% | 394 |
|
|
2020
Q4 | $61.6M | Buy |
287,173
+40,992
| +17% | +$7.95M | 0.06% | 361 |
|
|
2020
Q3 | $45M | Buy |
246,181
+19,958
| +9% | +$3.76M | 0.05% | 390 |
|
|
2020
Q2 | $41.7M | Buy |
226,223
+61,230
| +37% | +$12.2M | 0.05% | 400 |
|
|
2020
Q1 | $33.3M | Buy |
164,993
+12,794
| +8% | +$2.46M | 0.05% | 399 |
|
|
2019
Q4 | $28.5M | Buy |
152,199
+13,439
| +10% | +$2.31M | 0.03% | 510 |
|
|
2019
Q3 | $22.1M | Buy |
138,760
+137,650
| +12,401% | +$27.4M | 0.03% | 552 |
|
|
2019
Q2 | $280K | Sell |
1,110
-57
| -5% | -$13.2K | ﹤0.01% | 1421 |
|
|
2019
Q1 | $279K | Sell |
1,167
-136
| -10% | -$32.6K | ﹤0.01% | 1386 |
|
|
2018
Q4 | $299K | Sell |
1,303
-186
| -12% | -$45.9K | ﹤0.01% | 1362 |
|
|
2018
Q3 | $421K | Sell |
1,489
-321
| -18% | -$94K | ﹤0.01% | 1346 |
|
|
2018
Q2 | $532K | Sell |
1,810
-198
| -10% | -$54.1K | ﹤0.01% | 1383 |
|
|
2018
Q1 | $507K | Sell |
2,008
-14
| -0.7% | -$3.29K | ﹤0.01% | 1347 |
|
|
2017
Q4 | $437K | Sell |
2,022
-177
| -8% | -$35.8K | ﹤0.01% | 1433 |
|
|
2017
Q3 | $409K | Buy |
2,199
+90
| +4% | +$15.7K | ﹤0.01% | 1347 |
|
|
2017
Q2 | $364K | Buy |
2,109
+194
| +10% | +$31.1K | ﹤0.01% | 1373 |
|
|
2017
Q1 | $292K | Buy |
1,915
+524
| +38% | +$76.6K | ﹤0.01% | 1430 |
|
|
2016
Q4 | $205K | Buy |
+1,391
| New | +$201K | ﹤0.01% | 1528 |
|
|
2013
Q3 | – | Sell |
-31,300
| Closed | -$2.25M | – | 1633 |
|
|
2013
Q2 | $2.25M | Buy |
+31,300
| New | +$2.07M | ﹤0.01% | 1022 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Neuberger Berman Group's ICUI Position: Q1 2026 in Review
Neuberger Berman Group reduced its ICU Medical (ICUI) stake by 21% in Q1 2026, selling an estimated $16.9M and leaving 446,419 shares worth $57.7M. The position accounts for 0.04% of the portfolio, ranked #447.
Neuberger Berman Group first reported a position in ICUI in Q2 2013 and has held it in 39 quarters since. The position peaked at $90.7M in Q4 2021. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Neuberger Berman Group held 446,419 shares of ICU Medical worth $57.7M as of Q1 2026.
- Neuberger Berman Group sold 117,414 ICU Medical shares in Q1 2026, an estimated $16.9M.
- ICU Medical made up 0.04% of Neuberger Berman Group's portfolio in Q1 2026, its #447 holding.
- Neuberger Berman Group first reported a position in ICU Medical in Q2 2013 and has held it in 39 quarters since.
- Neuberger Berman Group's ICU Medical position peaked at $90.7M in Q4 2021.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.